Çocukluk Çağı Jeneralize Nöbet ve Epilepsileri
Özet
Çocukluk çağı jeneralize epilepsi sendromlarının çoğunun genetik veya genetik olduğu varsayılan bir etiyolojisi vardır. Bu nedenle, ILAE bu bozuklukları genetik jeneralize epilepsiler olarak sınıflandırmaktadır. Jeneralize nöbet semiyolojileri (miyoklonik, absans, miyoklonik-tonik-klonik ve/veya jeneralize tonik-klonik) ve nöbetler dışında elektrografik jeneralize deşarjlar ile karakterize edilmektedir. Genetik jeneralize epilepsiler, idiyopatik jeneralize epilepsiler (IJE) olarak bilinen tanımlanmış klinik sendromları içermektedir; bazı gelişimsel epileptik ensefalopatiler de (GEE) genetik jeneralize epilepsi kriterlerini karşılamaktadır.
Most childhood generalized epilepsy syndromes have a genetic or presumed genetic etiology. Therefore, the ILAE classifies these disorders as genetic generalized epilepsies. It is characterized by generalized seizure semiologies (myoclonic, absence, myoclonic-tonic-clonic and/or generalized tonic-clonic) and electrographic generalized discharges other than seizures. Genetic generalized epilepsies include defined clinical syndromes known as idiopathic generalized epilepsies (IGE); Some developmental epileptic encephalopathies (DEE) also meet criteria for genetic generalized epilepsy.
Referanslar
Berg AT, Millichap JJ. The 2010 revised classification of seizures and epilepsy. Continuum (Minneap Minn) 2013;19:571–597.
Blume WT, Luders HO, Mizrahi E, et al. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001;42:1212–1218.
Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981;22:489–501.
Fisher, R.S., Cross, J.H., French, J.A., Higurashi, N., Hirsch, E., Jansen, F.E., Lagae, L., Moshe, S.L., Peltola, J., Roulet Perez, E., Scheffer, I.E., Zuberi, S.M., 2017. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia 58 (4), 522–530.
Collaborators, G.B.D.N., 2019. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18 (5), 459–480.
Hirsch, E., French, J., Scheffer, I.E., Bogacz, A., Alsaadi, T., Sperling, M.R., Abdulla, F., Zuberi, S.M., Trinka, E., Specchio, N., Somerville, E., Samia, P., Riney, K., Nabbout, R., Jain, S., Wilmshurst, J.M., Auvin, S., Wiebe, S., Perucca, E., Moshe, S.L., Tinuper, P., Wirrell, E.C., 2022. ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: position statement by the ILAE task force on nosology and definitions. Epilepsia 63 (6), 1475–1499.
Wirrell, E.C., Nabbout, R., Scheffer, I.E., Alsaadi, T., Bogacz, A., French, J.A., Hirsch, E., Jain, S., Kaneko, S., Riney, K., Samia, P., Snead, O.C., Somerville, E., Specchio, N., Trinka, E., Zuberi, S.M., Balestrini, S., Wiebe, S., Cross, J.H., Perucca, E., Moshe, S.L., Tinuper, P., 2022. Methodology for classification and definition of epilepsy syndromes with list of syndromes: report of the ILAE Task Force on Nosology and Definitions. Epilepsia 63 (6), 1333–1348.
Beydoun, A., D’Souza, J., 2012. Treatment of idiopathic generalized epilepsy - a review of the evidence. Expert. Opin. Pharmacother. 13 (9), 1283–1298 Beydoun, A., D’Souza, J., 2012. Treatment of idiopathic generalized epilepsy - a review of the evidence. Expert. Opin. Pharmacother. 13 (9), 1283–1298.
Mastroianni, G., Ascoli, M., Gasparini, S., Brigo, F., Cianci, V., Neri, S., Russo, E., Aguglia, U., Ferlazzo, E., 2021. Therapeutic approach to difficult-to-treat typical absences and related epilepsy syndromes. Expert. Rev. Clin. Pharmacol. 14 (11), 1427–1433.
Wirrell, E.C., Camfield, C.S., Camfield, P.R., Gordon, K.E., Dooley, J.M., 1996. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenilemyoclonic epilepsy. Neurology 47 (4), 912–918.
Blom, S., Heijbel, J., Bergfors, P.G., 1978. Incidence of epilepsy in children: a follow-up study three years after the first seizure. Epilepsia 19 (4), 343–350
Salvati, K.A., Beenhakker, M.P., 2019. Out of thin air: hyperventilation-triggered seizures. Brain Res. 1703, 41–52.
Seneviratne, U., Hepworth, G., Cook, M., DʼSouza, W., 2017. Can EEG differentiate among syndromes in genetic generalized epilepsy? J. Clin. Neurophysiol. 34 (3), 213–221.
Elmali, A.D., Auvin, S., Bast, T., Rubboli, G., Koutroumanidis, M., 2020. How to diagnose and classify idiopathic (genetic) generalized epilepsies. Epileptic Disord 22 (4), 399–420.
Kessler, S. K., S. Shinnar, A. Cnaan, D. Dlugos, J. Conry, D. G. Hirtz, F. Hu, C. Liu, E. M.Mizrahi, S. L. Moshe, P. Clark, T. A. Glauser and G. Childhood Absence Epilepsy Study (2017). “Pretreatment seizure semiology in childhood absence epilepsy.” Neurology 89(7): 673-679.
Wirrell, E.C., Grossardt, B.R., Wong-Kisiel, L.C., Nickels, K.C., 2011. Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: a population-based study. Epilepsy Res. 95 (1–2), 110–118.
Trinka, E., Baumgartner, S., Unterberger, I., Unterrainer, J., Luef, G., Haberlandt, E., Bauer, G., 2004. Long-term prognosis for childhood and juvenile absence epilepsy. J. Neurol. 251 (10), 1235–1241.
Asadi-Pooya, A.A., Homayoun, M., 2020. Idiopathic (genetic) generalized epilepsies with absences: clinical and electrographic characteristics and seizure outcome. Neurol.Sci. 41 (12), 3677–3682.
Nordli DR Jr. Idiopathic generalized epilepsies recognized by the International League Against Epilepsy. Epilepsia. 2005;46(9):48-56).
Syvertsen, M., Hellum, M.K., Hansen, G., Edland, A., Nakken, K.O., Selmer, K.K., Koht, J., 2017. Prevalence of juvenile myoclonic epilepsy in people <30 years of age-A population-based study in Norway. Epilepsia 58 (1), 105–112.
Jain, S., Padma, M.V., Puri, A., Maheshwari, M.C., 1998. Juvenile myoclonic epilepsy: disease expression among Indian families. Acta Neurol. Scand. 97 (1), 1–7.
Yacubian, E.M., 2017. Juvenile myoclonic epilepsy: challenges on its 60th anniversary.Seizure 44, 48–52.
Wandschneider, B., Thompson, P.J., Vollmar, C., Koepp, M.J., 2012. Frontal lobe function and structure in juvenile myoclonic epilepsy: a comprehensive review of neuropsychological and imaging data. Epilepsia 53 (12), 2091–2098.
Chawla, T., Chaudhry, N., Puri, V., 2021. Cognitive dysfunction in Juvenile Myoclonic Epilepsy (JME) - A tertiary care center study. Ann. Indian Acad. Neurol. 24 (1),40–50
Machado RA, Garcia VF, Astencio AG, Cuartas VB.Efficacy and tolerability of lamotrigin in juvenile myoclonic epilepsy in adults:a prospective randomized controlled trial , unblinded.Seizure.2013;22(10):846-55.
Geithner, J., Schneider, F., Wang, Z., Berneiser, J., Herzer, R., Kessler, C., Runge, U.,2012. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up. Epilepsia 53 (8), 1379–1386.
Vorderwülbecke, B.J., Kowski,A.B., Kirschbaum, A., Merkle, H., Senf, P., Janz, D., Holtkamp, M., 2017. Long-term outcome in adolescent-onset generalized genetic epilepsies. Epilepsia 58 (7), 1244–1250.
Holtkamp, M., Kowski, A.B., Merkle, H., Janz, D., 2014. Long-term outcome in epilepsy with grand mal on awakening: forty years of follow-up. Ann. Neurol. 75 (2), 298–302.
Abarrategui, B., Parejo-Carbonell, B., García García, M.E., Di Capua, D., GarcíaMorales, I., 2018. The cognitive phenotype of idiopathic generalized epilepsy. Epilepsy Behav. 89, 99–104.
Rohracher, A., Brigo, F., Hofler, ¨ J., Kalss, G., Neuray, C., Dobesberger, J.,Kuchukhidze, G., Leitinger, M., Trinka, E., 2016. Perampanel for the treatment ofprimary generalized tonic-clonic seizures in idiopathic generalized epilepsy. Expert.Opin. Pharmacother. 17 (10), 1403–1411.
Guerrini, R., Conti, V., Mantegazza, M., Balestrini, S., Galanopoulou, A.S., Benfenati, F., 2023. Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum. Physiol. Rev. 103 (1), 433–513.
Helbig, I., 2015. Genetic causes of generalized epilepsies. Semin. Neurol. 35 (3), 288–292.
Symonds, J.D., Zuberi, S.M., Stewart, K., McLellan, A., O’Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., Pilz, D.T., Shetty, J., Dorris, L., Abu-Arafeh, I., Andrew, J., Brink, P., Callaghan, M., Cruden, J., Diver, L.A., Findlay, C., Gardiner, S., Grattan, R., Lang, B., MacDonnell, J., McKnight, J., Morrison, C.A., Nairn, L., Slean, M.M., Stephen, E., Webb, A., Vincent, A., Wilson, M., 2019. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Brain 142 (8), 2303–2318.
Aledo-Serrano, A., S´anchez-Alcudia, R., Toledano, R., García-Morales, I., Beltr´an- Corbellini, ´A., del Pino, I., Gil-Nagel, A., 2021. Developmental and epileptic encephalopathies after negative or inconclusive genetic testing: What is next? J. Transl. Genet. Genom. 5 (4), 443–455.
Strzelczyk, A., Schubert-Bast, S., 2022. Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies. CNS Drugs 36 (10), 1079–1111.
Elkommos, S., Mula, M., 2022. Current and future pharmacotherapy options for drug-resistant epilepsy. Expert. Opin. Pharmacother. 23 (18), 2023–2034.
Sondhi, V., Agarwala, A., Pandey, R.M., Chakrabarty, B., Jauhari, P., Lodha, R., Toteja, G.S., Sharma, S., Paul, V.K., Kossoff, E., Gulati, S., 2020. Efficacy of ketogenic diet, modified atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: a randomized clinical trial. JAMA Pediatr. 174 (10), 944–951.
McTague, A., Howell, K.B., Cross, J.H., Kurian, M.A., Scheffer, I.E., 2016. The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol. 15 (3), 304–316.
Stamberger, H., Nikanorova, M., Willemsen, M.H., Accorsi, P., Angriman, M., Baier, H., Benkel-Herrenbrueck, I., Benoit, V., Budetta, M., Caliebe, A., Cantalupo, G., Capovilla, G., Casara, G., Courage, C., Deprez, M., Destree, A., Dilena, R., Erasmus, C. E., Fannemel, M., Fjaer, R., Giordano, L., Helbig, K.L., Heyne, H.O., Klepper, J., Kluger, G.J., Lederer, D., Lodi, M., Maier, O., Merkenschlager, A., Michelberger, N., Minetti, C., Muhle, H., Phalin, J., Ramsey, K., Romeo, A., Schallner, J., Schanze, I., Shinawi, M., Sleegers, K., Sterbova, K., Syrbe, S., Traverso, M., Tzschach, A., Uldall, P., Van Coster, R., Verhelst, H., Viri, M., Winter, S., Wolff, M., Zenker, M., Zoccante, L., De Jonghe, P., Helbig, I., Striano, P., Lemke, J.R., Moller, R.S., Weckhuysen, S., 2016. STXBP1 encephalopathy: a neurodevelopmental disorder including epilepsy. Neurology 86 (10), 954–962.
Hirsch E, French J, Scheffer I, Zuberi S, Trinka E, Specchio N. Definition of the idiopathic generalized epilepsy syndromes: position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia. In press.
Ames FR, Saffer D. The sunflower syndrome. A new look at “self-induced” photosensitive epilepsy. J Neurol Sci. 1983;59(1):1–11
Wang X-L, Bao J-X, Liang-Shi, Tie-Ma, Deng Y-C, Zhao G, et al. Jeavons syndrome in China. Epilepsy Behav. 2014;32:64–71.
Giannakodimos S, Panayiotopoulos CP. Eyelid myoclonia with absences in adults: a clinical and video-EEG study. Epilepsia. 1996;37(1):36–44.
Covanis A. Eyelid myoclonia and absence. Adv Neurol. 2005;95:185–96.
Appleton RE, Panayiotopoulos CP, Acomb BA, Beirne M. Eyelid myoclonia with typical absences: an epilepsy syndrome. J Neurol Neurosurg Psychiatry. 1993;56(12):1312–6
Baumer FM, Porter BE. Clinical and electrographic features of sunflower syndrome. Epilepsy Res. 2018;142:58–63.
Smith KM, Youssef PE, Wirrell EC, Nickels KC, Payne ET, Britton JW, et al. Jeavons syndrome: clinical features and response to treatment. Pediatr Neurol. 2018;86:46–51.
Panayiotopoulos CP. Syndromes of idiopathic generalized epilepsies not recognized by the International League Against Epilepsy. Epilepsia. 2005;46(Suppl 9):57–66.
Striano S, Striano P, Nocerino C, Boccella P, Bilo L, Meo R, et al. Eyelid myoclonia with absences: an overlooked epileptic syndrome? Neurophysiol Clin Neurophysiol. 2002;32(5):287–96
Camfield CS, Camfield PR, Sadler M, Rahey S, Farrell K, Chayasirisobbon S, et al. Paroxysmal eyelid movements: a confusing feature of generalized photosensitive epilepsy. Neurology. 2004;63(1):40–2.
Belcastro V, Striano P. Self-induction seizures in sunflower epilepsy: a video-EEG report. Epileptic Disord. 2014;16(1):93–5
Striano S, Capovilla G, Sofia V, Romeo A, Rubboli G, Striano P, et al. Eyelid myoclonia with absences (Jeavons syndrome): a well-defined idiopathic generalized epilepsy syndrome or a spectrum of photosensitive conditions? Epilepsia. 2009;50:15–9
Singhi PD, Bansal D. Self induced photosensitive epilepsy. Indian J Pediatr. 2004;71(7):649–51.
Sadleir LG, Vears D, Regan B, Redshaw N, Bleasel A, Scheffer IE. Family studies of individuals with eyelid myoclonia with absences. Epilepsia. 2012;53(12):2141–8
Kasteleijn-Nolst Trenité D, Rubboli G, Hirsch E, Martins da Silva A, Seri S, Wilkins A, et al. Methodology of photic stimulation revisited: updated European algorithm for visual stimulation in the EEG laboratory. Epilepsia. 2012;53(1):16–24.
Capovilla G, Striano P, Gambardella A, Beccaria F, Hirsch E, Casellato S, et al. Eyelid fluttering, typical EEG pattern, and impaired intellectual function: a homogeneous epileptic condition among the patients presenting with eyelid myoclonia. Epilepsia. 2009;50(6):1536–41
Bureau M, Tassinari CA. Epilepsy with myoclonic absences. Brain Dev. 2005;27(3):178–84.
Genton P, Bureau M. Epilepsy with myoclonic absences. CNS Drugs. 2006;20(11):911–6.
. Zanzmera P, Menon RN, Karkare K, Soni H, Jagtap S, Radhakrishnan A. Epilepsy with myoclonic absences: electroclinical characteristics in a distinctive pediatric epilepsy phenotype. Epilepsy Behav. 2016;64:242–7
Myers KA, Scheffer IE. Myoclonic absence seizures with complex gestural automatisms. Eur J Paediatr Neurol. 2018;22(3):532–5.
Elia M, Guerrini R, Musumeci SA, Bonanni P, Gambardella A, Aguglia U. Myoclonic absence-like seizures and chromosome abnormality syndromes. Epilepsia. 1998;39(6):660–3.
Myers KA, Scheffer IE. Myoclonic absence seizures in Dravet syndrome. Pediatr Neurol. 2017;70:67–9
Bahi-Buisson N, El Sabbagh S, Soufflet C, Escande F, Boddaert N, Valayannopoulos V, et al. Myoclonic absence epilepsy with photosensitivity and a gain of function mutation in glutamate dehydrogenase. Seizure. 2008;17(7):658–64
Doose H. Myoclonic-astatic epilepsy. Epilepsy Res Suppl. 1992;6:163–8.
Kelley SA, Kossoff EH. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol. 2010;52(11):988–93
Tang S, Pal DK. Dissecting the genetic basis of myoclonicastatic epilepsy. Epilepsia. 2012;53(8):1303–13.
Doose H, Gerken H, Leonhardt R, Völzke E, Völz C. Centrencephalic myoclonic-astatic petit mal 1—clinical and genetic investigations. Neuropediatrics. 1970;2(1):59–78.
Neubauer BA, Hahn A, Doose H, Tuxhorn I. Myoclonic-astatic epilepsy of early childhood—definition, course, nosography, and genetics. Adv Neurol. 2005;95:147–55.
Kilaru S, Bergqvist AGC. Current treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia. 2007;48(9):1703–7.
. Kaminska A, Ickowicz A, Plouin P, Bru M, Dellatolas G, Dulac O. Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res. 1999;36(1):15–29
Joshi C, Nickels K, Demarest S, Eltze C, Cross JH, Wirrell E. Results of an international Delphi consensus in epilepsy with myoclonic atonic seizures/Doose syndrome. Seizure. 2021;85:12–8.
Oguni H, Tanaka T, Hayashi K, Funatsuka M, Sakauchi M, Shirakawa S, et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics. 2002;33(3):122–32.
. Trivisano M, Specchio N, Cappelletti S, Di Ciommo V, Claps D, SpecchioLM, et al.Myoclonic astatic epilepsy: anage-dependent epileptic syndrome with favorable seizure outcome but variable cognitive evolution. Epilepsy Res. 2011;97(1–2):133–41.
Caraballo RH, Chamorro N, Darra F, Fortini S, Arroyo H. Epilepsy with myoclonic atonic seizures: an electroclinical study of 69 patients. Pediatr Neurol. 2013;48(5):355–62.
Eschbach K, Moss A, Joshi C, Angione K, Smith G, Dempsey A, et al. Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures. Epilepsy Res. 2018;147:95–101
Oguni H, Hayashi K, Imai K, Funatsuka M, Sakauchi M, Shirakawa S, et al.Idiopathic myoclonic-astatic epilepsy of early childhood—nosology based on electrophysiologic and longterm follow-up study of patients. Adv Neurol. 2005;95:157–74.
Caraballo RH, Chamorro N, Darra F, Fortini S, Arroyo H. Epilepsy with myoclonic atonic seizures: an electroclinical study of 69 patients. Pediatr Neurol. 2013;48(5):355–62.
Nabbout R. Absence of mutations in major GEFS+ genes in myoclonic astatic epilepsy. Epilepsy Res. 2003;56(2–3):127–33.
Wallace RH, Scheffer IE, Barnett S, Richards M, Dibbens L, Desai RR, et al. Neuronal sodium-channel α1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet. 2001;68(4):859–65
Wallace RH, Wang DW, Singh R, Scheffer IE, George AL, Phillips HA, et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel ß1 subunit gene SCN1B. Nat Genet. 1998;19(4):366–70.
Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, et al. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain. 2017;140(5):1316–36.
Schubert J, Siekierska A, Langlois M, May P, Huneau C, Becker F, et al. Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes. Nat Genet. 2014;46(12):1327–32.
Carvill G, McMahon J, Schneider A, Zemel M, Myers C, Saykally J, et al. Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonic-atonic seizures. Am J Hum Genet. 2015;96(5):808–15
Thomas RH, Zhang LM, Carvill GL, Archer JS, Heavin SB, Mandelstam SA, et al. CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures. Neurology. 2015;84(9):951–8
Vlaskamp DRM, Shaw BJ, Burgess R, Mei D, Montomoli M, Xie H, et al. SYNGAP1 encephalopathy. Neurology. 2019;92(2):e96–107.
Stamberger H, Hammer TB, Gardella E, Vlaskamp DRM, Bertelsen B, Mandelstam S, et al. NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns. Genet Med. 2021;23(2):363–73.
Arsov T, Mullen SA, Rogers S, Phillips AM, Lawrence KM, Damiano JA, et al. Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol. 2012;72(5):807–15.
. Genton P, Guerrini R, Dravet C. The Lennox-Gsataut syndrome. In: Meinardi H, editor. Handbook of clinical neurology: the epilepsies. Amsterdam, the Netherlands: Elsevier; 2000. p. 211–22
Berg AT, Levy SR, Testa FM. Evolution and course of early life developmental encephalopathic epilepsies: focus on LennoxGastaut syndrome. Epilepsia. 2018;59(11):2096–105
Goldsmith IL, Zupanc ML, Buchhalter JR. Long-term seizure outcome in 74 patients with Lennox-Gastaut syndrome: effects of incorporating MRI head imaging in defining the cryptogenic subgroup. Epilepsia. 2000;41(4):395–9
Vignoli A, Oggioni G, De Maria G, Peron A, Savini MN, Zambrelli E, et al. Lennox-Gastaut syndrome in adulthood: long-term clinical follow-up of 38 patients and analysis of their recorded seizures. Epilepsy Behav. 2017;77:73–8.
Kerr M, Kluger G, Philip S. Evolution and management of Lennox-Gastaut syndrome through adolescence and into adulthood: are seizures always the primary issue? Epileptic Disord. 2011;13(S1):15–26.
Kim HJ, Kim HD, Lee JS, Heo K, Kim D-S, Kang H-C. Longterm prognosis of patients with Lennox-Gastaut syndrome in recent decades. Epilepsy Res. 2015;110:10–9
Ferlazzo E, Nikaronova M, Italiano D, Bureau M, Dravet C, Calarese T, et al. Lennox-Gastaut syndrome in adulthood: clinical and EEG features. Epilepsy Res. 2010;89(2–3):271–7.
Ohtsuka Y, Amano R, Mizukawa M, Ohtahara S. Long-term prognosis of the Lennox-Gastaut syndrome. Psychiatry Clin Neurosci. 1990;44(2):257–64.
Hughes JR, Patil VK. Long term electro-clinical changes in the Lennox-Gastaut syndrome before, during, and after the slow spike-wave pattern. Clin Electroencephalogr. 2002;33(1):1–7.
Lee YJ, Kang H-C, Lee JS, Kim SH, Kim D-S, Shim K-W, et al. Resective pediatric epilepsy surgery in Lennox-Gastaut syndrome. Pediatrics. 2010;125(1):e58–66.
Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF, Cossette P, Delanty N, et al. De novo mutations in epileptic encephalopathies. Nature. 2013;501(7466):217–21.
Asadi-Pooya AA. Lennox-Gastaut syndrome: a comprehensive review. Neurol Sci. 2018;39(3):403–14
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51(4):676–85.
Fernández IS, Chapman KE, Peters JM, Kothare SV, Nordli DR, Jensen FE, et al. The Tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia. 2013;54(4):741–50
Eksioglu Y, Tas E, Takeoka M, Sarco D, Rotemberg A. Clinical presentation and acute treatment of electricalstatus epilepticus in sleep and sleep potentiated spikes. Philadelphia, PA: Medical Publishing Practice; 2009. p. A434.
Morikawa T, Seino M, Watanabe Y, Watanabe M, Yagi K. Clinical relevance of continuous spike-waves during slow wave sleep. In: Manelis S, Bental E, Loeber J, Dreifuss F, editors. Advances in epileptology. New York, NY: Raven Press; 1989. p. 359–63.
Singhal NS, Sullivan JE. Continuous spike-wave during slow wave sleep and related conditions. ISRN Neurol. 2014;2014:1–6.
Kersbergen KJ, de Vries LS, Leijten FSS, Braun KPJ, Nievelstein RAJ, Groenendaal F, et al. Neonatal thalamic hemorrhage is strongly associated with electrical status epilepticus in slow wave sleep. Epilepsia. 2013;54(4):733–40.
Neville BGR, Boyd SG. Selective epileptic gait disorder.J Neurol Neurosurg Psychiatry. 1995;58(3):371–3.
Caraballo R, Pavlidis E, Nikanorova M, Loddenkemper T. Encephalopathy with continuous spike-waves during slowwave sleep: evolution and prognosis. Epileptic Disord. 2019;21(S1):15–21
Gardella E, Cantalupo G, Larsson PG, Fontana E, Bernardina BD, Rubboli G, et al. EEG features in encephalopathy related to status epilepticus during slow sleep. Epileptic Disord. 2019;21(S1):22–30.
Loddenkemper T, Fernández IS, Peters JM. Continuous spike and waves during sleep and electrical status epilepticus in sleep. J Clin Neurophysiol. 2011;28(2):154–64.
Tassinari CA, Cantalupo G, Rios-Pohl L, Della GE, Rubboli G. Encephalopathy with status epilepticus during slow sleep: “the Penelope syndrome”. Epilepsia. 2009;50:4–8.
Van Bogaert P. Epileptic encephalopathy with continuous spike-waves during slow-wave sleep including Landau-Kleffner syndrome. Handb Clin Neurol. 2013;111:635–40.
Tsai M-H, Vears DF, Turner SJ, Smith RL, Berkovic SF, Sadleir LG, et al. Clinical genetic study of the epilepsy-aphasia spectrum. Epilepsia. 2013;54(2):280–7.
Referanslar
Berg AT, Millichap JJ. The 2010 revised classification of seizures and epilepsy. Continuum (Minneap Minn) 2013;19:571–597.
Blume WT, Luders HO, Mizrahi E, et al. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001;42:1212–1218.
Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981;22:489–501.
Fisher, R.S., Cross, J.H., French, J.A., Higurashi, N., Hirsch, E., Jansen, F.E., Lagae, L., Moshe, S.L., Peltola, J., Roulet Perez, E., Scheffer, I.E., Zuberi, S.M., 2017. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia 58 (4), 522–530.
Collaborators, G.B.D.N., 2019. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18 (5), 459–480.
Hirsch, E., French, J., Scheffer, I.E., Bogacz, A., Alsaadi, T., Sperling, M.R., Abdulla, F., Zuberi, S.M., Trinka, E., Specchio, N., Somerville, E., Samia, P., Riney, K., Nabbout, R., Jain, S., Wilmshurst, J.M., Auvin, S., Wiebe, S., Perucca, E., Moshe, S.L., Tinuper, P., Wirrell, E.C., 2022. ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: position statement by the ILAE task force on nosology and definitions. Epilepsia 63 (6), 1475–1499.
Wirrell, E.C., Nabbout, R., Scheffer, I.E., Alsaadi, T., Bogacz, A., French, J.A., Hirsch, E., Jain, S., Kaneko, S., Riney, K., Samia, P., Snead, O.C., Somerville, E., Specchio, N., Trinka, E., Zuberi, S.M., Balestrini, S., Wiebe, S., Cross, J.H., Perucca, E., Moshe, S.L., Tinuper, P., 2022. Methodology for classification and definition of epilepsy syndromes with list of syndromes: report of the ILAE Task Force on Nosology and Definitions. Epilepsia 63 (6), 1333–1348.
Beydoun, A., D’Souza, J., 2012. Treatment of idiopathic generalized epilepsy - a review of the evidence. Expert. Opin. Pharmacother. 13 (9), 1283–1298 Beydoun, A., D’Souza, J., 2012. Treatment of idiopathic generalized epilepsy - a review of the evidence. Expert. Opin. Pharmacother. 13 (9), 1283–1298.
Mastroianni, G., Ascoli, M., Gasparini, S., Brigo, F., Cianci, V., Neri, S., Russo, E., Aguglia, U., Ferlazzo, E., 2021. Therapeutic approach to difficult-to-treat typical absences and related epilepsy syndromes. Expert. Rev. Clin. Pharmacol. 14 (11), 1427–1433.
Wirrell, E.C., Camfield, C.S., Camfield, P.R., Gordon, K.E., Dooley, J.M., 1996. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenilemyoclonic epilepsy. Neurology 47 (4), 912–918.
Blom, S., Heijbel, J., Bergfors, P.G., 1978. Incidence of epilepsy in children: a follow-up study three years after the first seizure. Epilepsia 19 (4), 343–350
Salvati, K.A., Beenhakker, M.P., 2019. Out of thin air: hyperventilation-triggered seizures. Brain Res. 1703, 41–52.
Seneviratne, U., Hepworth, G., Cook, M., DʼSouza, W., 2017. Can EEG differentiate among syndromes in genetic generalized epilepsy? J. Clin. Neurophysiol. 34 (3), 213–221.
Elmali, A.D., Auvin, S., Bast, T., Rubboli, G., Koutroumanidis, M., 2020. How to diagnose and classify idiopathic (genetic) generalized epilepsies. Epileptic Disord 22 (4), 399–420.
Kessler, S. K., S. Shinnar, A. Cnaan, D. Dlugos, J. Conry, D. G. Hirtz, F. Hu, C. Liu, E. M.Mizrahi, S. L. Moshe, P. Clark, T. A. Glauser and G. Childhood Absence Epilepsy Study (2017). “Pretreatment seizure semiology in childhood absence epilepsy.” Neurology 89(7): 673-679.
Wirrell, E.C., Grossardt, B.R., Wong-Kisiel, L.C., Nickels, K.C., 2011. Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: a population-based study. Epilepsy Res. 95 (1–2), 110–118.
Trinka, E., Baumgartner, S., Unterberger, I., Unterrainer, J., Luef, G., Haberlandt, E., Bauer, G., 2004. Long-term prognosis for childhood and juvenile absence epilepsy. J. Neurol. 251 (10), 1235–1241.
Asadi-Pooya, A.A., Homayoun, M., 2020. Idiopathic (genetic) generalized epilepsies with absences: clinical and electrographic characteristics and seizure outcome. Neurol.Sci. 41 (12), 3677–3682.
Nordli DR Jr. Idiopathic generalized epilepsies recognized by the International League Against Epilepsy. Epilepsia. 2005;46(9):48-56).
Syvertsen, M., Hellum, M.K., Hansen, G., Edland, A., Nakken, K.O., Selmer, K.K., Koht, J., 2017. Prevalence of juvenile myoclonic epilepsy in people <30 years of age-A population-based study in Norway. Epilepsia 58 (1), 105–112.
Jain, S., Padma, M.V., Puri, A., Maheshwari, M.C., 1998. Juvenile myoclonic epilepsy: disease expression among Indian families. Acta Neurol. Scand. 97 (1), 1–7.
Yacubian, E.M., 2017. Juvenile myoclonic epilepsy: challenges on its 60th anniversary.Seizure 44, 48–52.
Wandschneider, B., Thompson, P.J., Vollmar, C., Koepp, M.J., 2012. Frontal lobe function and structure in juvenile myoclonic epilepsy: a comprehensive review of neuropsychological and imaging data. Epilepsia 53 (12), 2091–2098.
Chawla, T., Chaudhry, N., Puri, V., 2021. Cognitive dysfunction in Juvenile Myoclonic Epilepsy (JME) - A tertiary care center study. Ann. Indian Acad. Neurol. 24 (1),40–50
Machado RA, Garcia VF, Astencio AG, Cuartas VB.Efficacy and tolerability of lamotrigin in juvenile myoclonic epilepsy in adults:a prospective randomized controlled trial , unblinded.Seizure.2013;22(10):846-55.
Geithner, J., Schneider, F., Wang, Z., Berneiser, J., Herzer, R., Kessler, C., Runge, U.,2012. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up. Epilepsia 53 (8), 1379–1386.
Vorderwülbecke, B.J., Kowski,A.B., Kirschbaum, A., Merkle, H., Senf, P., Janz, D., Holtkamp, M., 2017. Long-term outcome in adolescent-onset generalized genetic epilepsies. Epilepsia 58 (7), 1244–1250.
Holtkamp, M., Kowski, A.B., Merkle, H., Janz, D., 2014. Long-term outcome in epilepsy with grand mal on awakening: forty years of follow-up. Ann. Neurol. 75 (2), 298–302.
Abarrategui, B., Parejo-Carbonell, B., García García, M.E., Di Capua, D., GarcíaMorales, I., 2018. The cognitive phenotype of idiopathic generalized epilepsy. Epilepsy Behav. 89, 99–104.
Rohracher, A., Brigo, F., Hofler, ¨ J., Kalss, G., Neuray, C., Dobesberger, J.,Kuchukhidze, G., Leitinger, M., Trinka, E., 2016. Perampanel for the treatment ofprimary generalized tonic-clonic seizures in idiopathic generalized epilepsy. Expert.Opin. Pharmacother. 17 (10), 1403–1411.
Guerrini, R., Conti, V., Mantegazza, M., Balestrini, S., Galanopoulou, A.S., Benfenati, F., 2023. Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum. Physiol. Rev. 103 (1), 433–513.
Helbig, I., 2015. Genetic causes of generalized epilepsies. Semin. Neurol. 35 (3), 288–292.
Symonds, J.D., Zuberi, S.M., Stewart, K., McLellan, A., O’Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., Pilz, D.T., Shetty, J., Dorris, L., Abu-Arafeh, I., Andrew, J., Brink, P., Callaghan, M., Cruden, J., Diver, L.A., Findlay, C., Gardiner, S., Grattan, R., Lang, B., MacDonnell, J., McKnight, J., Morrison, C.A., Nairn, L., Slean, M.M., Stephen, E., Webb, A., Vincent, A., Wilson, M., 2019. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Brain 142 (8), 2303–2318.
Aledo-Serrano, A., S´anchez-Alcudia, R., Toledano, R., García-Morales, I., Beltr´an- Corbellini, ´A., del Pino, I., Gil-Nagel, A., 2021. Developmental and epileptic encephalopathies after negative or inconclusive genetic testing: What is next? J. Transl. Genet. Genom. 5 (4), 443–455.
Strzelczyk, A., Schubert-Bast, S., 2022. Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies. CNS Drugs 36 (10), 1079–1111.
Elkommos, S., Mula, M., 2022. Current and future pharmacotherapy options for drug-resistant epilepsy. Expert. Opin. Pharmacother. 23 (18), 2023–2034.
Sondhi, V., Agarwala, A., Pandey, R.M., Chakrabarty, B., Jauhari, P., Lodha, R., Toteja, G.S., Sharma, S., Paul, V.K., Kossoff, E., Gulati, S., 2020. Efficacy of ketogenic diet, modified atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: a randomized clinical trial. JAMA Pediatr. 174 (10), 944–951.
McTague, A., Howell, K.B., Cross, J.H., Kurian, M.A., Scheffer, I.E., 2016. The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol. 15 (3), 304–316.
Stamberger, H., Nikanorova, M., Willemsen, M.H., Accorsi, P., Angriman, M., Baier, H., Benkel-Herrenbrueck, I., Benoit, V., Budetta, M., Caliebe, A., Cantalupo, G., Capovilla, G., Casara, G., Courage, C., Deprez, M., Destree, A., Dilena, R., Erasmus, C. E., Fannemel, M., Fjaer, R., Giordano, L., Helbig, K.L., Heyne, H.O., Klepper, J., Kluger, G.J., Lederer, D., Lodi, M., Maier, O., Merkenschlager, A., Michelberger, N., Minetti, C., Muhle, H., Phalin, J., Ramsey, K., Romeo, A., Schallner, J., Schanze, I., Shinawi, M., Sleegers, K., Sterbova, K., Syrbe, S., Traverso, M., Tzschach, A., Uldall, P., Van Coster, R., Verhelst, H., Viri, M., Winter, S., Wolff, M., Zenker, M., Zoccante, L., De Jonghe, P., Helbig, I., Striano, P., Lemke, J.R., Moller, R.S., Weckhuysen, S., 2016. STXBP1 encephalopathy: a neurodevelopmental disorder including epilepsy. Neurology 86 (10), 954–962.
Hirsch E, French J, Scheffer I, Zuberi S, Trinka E, Specchio N. Definition of the idiopathic generalized epilepsy syndromes: position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia. In press.
Ames FR, Saffer D. The sunflower syndrome. A new look at “self-induced” photosensitive epilepsy. J Neurol Sci. 1983;59(1):1–11
Wang X-L, Bao J-X, Liang-Shi, Tie-Ma, Deng Y-C, Zhao G, et al. Jeavons syndrome in China. Epilepsy Behav. 2014;32:64–71.
Giannakodimos S, Panayiotopoulos CP. Eyelid myoclonia with absences in adults: a clinical and video-EEG study. Epilepsia. 1996;37(1):36–44.
Covanis A. Eyelid myoclonia and absence. Adv Neurol. 2005;95:185–96.
Appleton RE, Panayiotopoulos CP, Acomb BA, Beirne M. Eyelid myoclonia with typical absences: an epilepsy syndrome. J Neurol Neurosurg Psychiatry. 1993;56(12):1312–6
Baumer FM, Porter BE. Clinical and electrographic features of sunflower syndrome. Epilepsy Res. 2018;142:58–63.
Smith KM, Youssef PE, Wirrell EC, Nickels KC, Payne ET, Britton JW, et al. Jeavons syndrome: clinical features and response to treatment. Pediatr Neurol. 2018;86:46–51.
Panayiotopoulos CP. Syndromes of idiopathic generalized epilepsies not recognized by the International League Against Epilepsy. Epilepsia. 2005;46(Suppl 9):57–66.
Striano S, Striano P, Nocerino C, Boccella P, Bilo L, Meo R, et al. Eyelid myoclonia with absences: an overlooked epileptic syndrome? Neurophysiol Clin Neurophysiol. 2002;32(5):287–96
Camfield CS, Camfield PR, Sadler M, Rahey S, Farrell K, Chayasirisobbon S, et al. Paroxysmal eyelid movements: a confusing feature of generalized photosensitive epilepsy. Neurology. 2004;63(1):40–2.
Belcastro V, Striano P. Self-induction seizures in sunflower epilepsy: a video-EEG report. Epileptic Disord. 2014;16(1):93–5
Striano S, Capovilla G, Sofia V, Romeo A, Rubboli G, Striano P, et al. Eyelid myoclonia with absences (Jeavons syndrome): a well-defined idiopathic generalized epilepsy syndrome or a spectrum of photosensitive conditions? Epilepsia. 2009;50:15–9
Singhi PD, Bansal D. Self induced photosensitive epilepsy. Indian J Pediatr. 2004;71(7):649–51.
Sadleir LG, Vears D, Regan B, Redshaw N, Bleasel A, Scheffer IE. Family studies of individuals with eyelid myoclonia with absences. Epilepsia. 2012;53(12):2141–8
Kasteleijn-Nolst Trenité D, Rubboli G, Hirsch E, Martins da Silva A, Seri S, Wilkins A, et al. Methodology of photic stimulation revisited: updated European algorithm for visual stimulation in the EEG laboratory. Epilepsia. 2012;53(1):16–24.
Capovilla G, Striano P, Gambardella A, Beccaria F, Hirsch E, Casellato S, et al. Eyelid fluttering, typical EEG pattern, and impaired intellectual function: a homogeneous epileptic condition among the patients presenting with eyelid myoclonia. Epilepsia. 2009;50(6):1536–41
Bureau M, Tassinari CA. Epilepsy with myoclonic absences. Brain Dev. 2005;27(3):178–84.
Genton P, Bureau M. Epilepsy with myoclonic absences. CNS Drugs. 2006;20(11):911–6.
. Zanzmera P, Menon RN, Karkare K, Soni H, Jagtap S, Radhakrishnan A. Epilepsy with myoclonic absences: electroclinical characteristics in a distinctive pediatric epilepsy phenotype. Epilepsy Behav. 2016;64:242–7
Myers KA, Scheffer IE. Myoclonic absence seizures with complex gestural automatisms. Eur J Paediatr Neurol. 2018;22(3):532–5.
Elia M, Guerrini R, Musumeci SA, Bonanni P, Gambardella A, Aguglia U. Myoclonic absence-like seizures and chromosome abnormality syndromes. Epilepsia. 1998;39(6):660–3.
Myers KA, Scheffer IE. Myoclonic absence seizures in Dravet syndrome. Pediatr Neurol. 2017;70:67–9
Bahi-Buisson N, El Sabbagh S, Soufflet C, Escande F, Boddaert N, Valayannopoulos V, et al. Myoclonic absence epilepsy with photosensitivity and a gain of function mutation in glutamate dehydrogenase. Seizure. 2008;17(7):658–64
Doose H. Myoclonic-astatic epilepsy. Epilepsy Res Suppl. 1992;6:163–8.
Kelley SA, Kossoff EH. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol. 2010;52(11):988–93
Tang S, Pal DK. Dissecting the genetic basis of myoclonicastatic epilepsy. Epilepsia. 2012;53(8):1303–13.
Doose H, Gerken H, Leonhardt R, Völzke E, Völz C. Centrencephalic myoclonic-astatic petit mal 1—clinical and genetic investigations. Neuropediatrics. 1970;2(1):59–78.
Neubauer BA, Hahn A, Doose H, Tuxhorn I. Myoclonic-astatic epilepsy of early childhood—definition, course, nosography, and genetics. Adv Neurol. 2005;95:147–55.
Kilaru S, Bergqvist AGC. Current treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia. 2007;48(9):1703–7.
. Kaminska A, Ickowicz A, Plouin P, Bru M, Dellatolas G, Dulac O. Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res. 1999;36(1):15–29
Joshi C, Nickels K, Demarest S, Eltze C, Cross JH, Wirrell E. Results of an international Delphi consensus in epilepsy with myoclonic atonic seizures/Doose syndrome. Seizure. 2021;85:12–8.
Oguni H, Tanaka T, Hayashi K, Funatsuka M, Sakauchi M, Shirakawa S, et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics. 2002;33(3):122–32.
. Trivisano M, Specchio N, Cappelletti S, Di Ciommo V, Claps D, SpecchioLM, et al.Myoclonic astatic epilepsy: anage-dependent epileptic syndrome with favorable seizure outcome but variable cognitive evolution. Epilepsy Res. 2011;97(1–2):133–41.
Caraballo RH, Chamorro N, Darra F, Fortini S, Arroyo H. Epilepsy with myoclonic atonic seizures: an electroclinical study of 69 patients. Pediatr Neurol. 2013;48(5):355–62.
Eschbach K, Moss A, Joshi C, Angione K, Smith G, Dempsey A, et al. Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures. Epilepsy Res. 2018;147:95–101
Oguni H, Hayashi K, Imai K, Funatsuka M, Sakauchi M, Shirakawa S, et al.Idiopathic myoclonic-astatic epilepsy of early childhood—nosology based on electrophysiologic and longterm follow-up study of patients. Adv Neurol. 2005;95:157–74.
Caraballo RH, Chamorro N, Darra F, Fortini S, Arroyo H. Epilepsy with myoclonic atonic seizures: an electroclinical study of 69 patients. Pediatr Neurol. 2013;48(5):355–62.
Nabbout R. Absence of mutations in major GEFS+ genes in myoclonic astatic epilepsy. Epilepsy Res. 2003;56(2–3):127–33.
Wallace RH, Scheffer IE, Barnett S, Richards M, Dibbens L, Desai RR, et al. Neuronal sodium-channel α1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet. 2001;68(4):859–65
Wallace RH, Wang DW, Singh R, Scheffer IE, George AL, Phillips HA, et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel ß1 subunit gene SCN1B. Nat Genet. 1998;19(4):366–70.
Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, et al. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain. 2017;140(5):1316–36.
Schubert J, Siekierska A, Langlois M, May P, Huneau C, Becker F, et al. Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes. Nat Genet. 2014;46(12):1327–32.
Carvill G, McMahon J, Schneider A, Zemel M, Myers C, Saykally J, et al. Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonic-atonic seizures. Am J Hum Genet. 2015;96(5):808–15
Thomas RH, Zhang LM, Carvill GL, Archer JS, Heavin SB, Mandelstam SA, et al. CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures. Neurology. 2015;84(9):951–8
Vlaskamp DRM, Shaw BJ, Burgess R, Mei D, Montomoli M, Xie H, et al. SYNGAP1 encephalopathy. Neurology. 2019;92(2):e96–107.
Stamberger H, Hammer TB, Gardella E, Vlaskamp DRM, Bertelsen B, Mandelstam S, et al. NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns. Genet Med. 2021;23(2):363–73.
Arsov T, Mullen SA, Rogers S, Phillips AM, Lawrence KM, Damiano JA, et al. Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol. 2012;72(5):807–15.
. Genton P, Guerrini R, Dravet C. The Lennox-Gsataut syndrome. In: Meinardi H, editor. Handbook of clinical neurology: the epilepsies. Amsterdam, the Netherlands: Elsevier; 2000. p. 211–22
Berg AT, Levy SR, Testa FM. Evolution and course of early life developmental encephalopathic epilepsies: focus on LennoxGastaut syndrome. Epilepsia. 2018;59(11):2096–105
Goldsmith IL, Zupanc ML, Buchhalter JR. Long-term seizure outcome in 74 patients with Lennox-Gastaut syndrome: effects of incorporating MRI head imaging in defining the cryptogenic subgroup. Epilepsia. 2000;41(4):395–9
Vignoli A, Oggioni G, De Maria G, Peron A, Savini MN, Zambrelli E, et al. Lennox-Gastaut syndrome in adulthood: long-term clinical follow-up of 38 patients and analysis of their recorded seizures. Epilepsy Behav. 2017;77:73–8.
Kerr M, Kluger G, Philip S. Evolution and management of Lennox-Gastaut syndrome through adolescence and into adulthood: are seizures always the primary issue? Epileptic Disord. 2011;13(S1):15–26.
Kim HJ, Kim HD, Lee JS, Heo K, Kim D-S, Kang H-C. Longterm prognosis of patients with Lennox-Gastaut syndrome in recent decades. Epilepsy Res. 2015;110:10–9
Ferlazzo E, Nikaronova M, Italiano D, Bureau M, Dravet C, Calarese T, et al. Lennox-Gastaut syndrome in adulthood: clinical and EEG features. Epilepsy Res. 2010;89(2–3):271–7.
Ohtsuka Y, Amano R, Mizukawa M, Ohtahara S. Long-term prognosis of the Lennox-Gastaut syndrome. Psychiatry Clin Neurosci. 1990;44(2):257–64.
Hughes JR, Patil VK. Long term electro-clinical changes in the Lennox-Gastaut syndrome before, during, and after the slow spike-wave pattern. Clin Electroencephalogr. 2002;33(1):1–7.
Lee YJ, Kang H-C, Lee JS, Kim SH, Kim D-S, Shim K-W, et al. Resective pediatric epilepsy surgery in Lennox-Gastaut syndrome. Pediatrics. 2010;125(1):e58–66.
Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF, Cossette P, Delanty N, et al. De novo mutations in epileptic encephalopathies. Nature. 2013;501(7466):217–21.
Asadi-Pooya AA. Lennox-Gastaut syndrome: a comprehensive review. Neurol Sci. 2018;39(3):403–14
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51(4):676–85.
Fernández IS, Chapman KE, Peters JM, Kothare SV, Nordli DR, Jensen FE, et al. The Tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia. 2013;54(4):741–50
Eksioglu Y, Tas E, Takeoka M, Sarco D, Rotemberg A. Clinical presentation and acute treatment of electricalstatus epilepticus in sleep and sleep potentiated spikes. Philadelphia, PA: Medical Publishing Practice; 2009. p. A434.
Morikawa T, Seino M, Watanabe Y, Watanabe M, Yagi K. Clinical relevance of continuous spike-waves during slow wave sleep. In: Manelis S, Bental E, Loeber J, Dreifuss F, editors. Advances in epileptology. New York, NY: Raven Press; 1989. p. 359–63.
Singhal NS, Sullivan JE. Continuous spike-wave during slow wave sleep and related conditions. ISRN Neurol. 2014;2014:1–6.
Kersbergen KJ, de Vries LS, Leijten FSS, Braun KPJ, Nievelstein RAJ, Groenendaal F, et al. Neonatal thalamic hemorrhage is strongly associated with electrical status epilepticus in slow wave sleep. Epilepsia. 2013;54(4):733–40.
Neville BGR, Boyd SG. Selective epileptic gait disorder.J Neurol Neurosurg Psychiatry. 1995;58(3):371–3.
Caraballo R, Pavlidis E, Nikanorova M, Loddenkemper T. Encephalopathy with continuous spike-waves during slowwave sleep: evolution and prognosis. Epileptic Disord. 2019;21(S1):15–21
Gardella E, Cantalupo G, Larsson PG, Fontana E, Bernardina BD, Rubboli G, et al. EEG features in encephalopathy related to status epilepticus during slow sleep. Epileptic Disord. 2019;21(S1):22–30.
Loddenkemper T, Fernández IS, Peters JM. Continuous spike and waves during sleep and electrical status epilepticus in sleep. J Clin Neurophysiol. 2011;28(2):154–64.
Tassinari CA, Cantalupo G, Rios-Pohl L, Della GE, Rubboli G. Encephalopathy with status epilepticus during slow sleep: “the Penelope syndrome”. Epilepsia. 2009;50:4–8.
Van Bogaert P. Epileptic encephalopathy with continuous spike-waves during slow-wave sleep including Landau-Kleffner syndrome. Handb Clin Neurol. 2013;111:635–40.
Tsai M-H, Vears DF, Turner SJ, Smith RL, Berkovic SF, Sadleir LG, et al. Clinical genetic study of the epilepsy-aphasia spectrum. Epilepsia. 2013;54(2):280–7.
